Association between MDM2 SNP309 and skin cancer: A meta-analysis of case-control studies.
暂无分享，去创建一个
[1] David E. Fisher,et al. The melanoma revolution: From UV carcinogenesis to a new era in therapeutics , 2014, Science.
[2] P. Bhandari,et al. Novel Medical Strategies Combating Nonmelanoma Skin Cancer , 2014, Indian journal of dermatology.
[3] K. Hemminki,et al. No association between MDM2 SNP309 promoter polymorphism and basal cell carcinoma of the skin , 2007, The British journal of dermatology.
[4] David E. Fisher,et al. Central Role of p53 in the Suntan Response and Pathologic Hyperpigmentation , 2007, Cell.
[5] D. Fisher,et al. Melanocyte biology and skin pigmentation , 2007, Nature.
[6] K. Hemminki,et al. Single nucleotide polymorphisms in DNA repair genes and basal cell carcinoma of skin. , 2005, Carcinogenesis.
[7] A. Levine,et al. A Single Nucleotide Polymorphism in the MDM2 Promoter Attenuates the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in Humans , 2004, Cell.
[8] M. Oren,et al. The p53-Mdm2 module and the ubiquitin system. , 2003, Seminars in cancer biology.
[9] V. Adler,et al. Mdm2 association with p53 targets its ubiquitination , 1998, Oncogene.
[10] T. Jacks,et al. Sunburn and p53 in the onset of skin cancer , 1994, Nature.